---
layout: default
title: Talks
---

# Talks & Presentations (selected)

- **NASPGHAN (2024)** — FXR agonist–mediated protection and STAT3 activation in inflammatory cholangiopathy  
- **AASLD (2023)** — STAT3 signaling mediating FXR agonist protection in acute cholangiopathy  
- **ESPGHAN (2022)** — LRH-1 agonist and macrophage activation in cholestasis  
